FCA
GILD icon

FinTrust Capital Advisors’s Gilead Sciences GILD Stock Holding History

FinTrust Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,000
Closed -$61K – 1162
2020
Q2 		$61K Hold
3,000
– – 0.02% 434
2020
Q1 		$59K Buy
+3,000
New +$207K 0.03% 395

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

FinTrust Capital Advisors's GILD Position: Q3 2024 in Review

FinTrust Capital Advisors increased its Gilead Sciences (GILD) stake by 1% in Q3 2024, buying an estimated $1.07K and bringing the position to 1,368 shares worth $115K. The position accounts for 0.02% of the portfolio, ranked #399.

FinTrust Capital Advisors first reported a position in GILD in Q4 2018 and has held it in 24 quarters since. The position peaked at $1.56M in Q2 2020. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • FinTrust Capital Advisors held 1,368 shares of Gilead Sciences worth $115K as of Q3 2024.
  • FinTrust Capital Advisors bought 14 Gilead Sciences shares in Q3 2024, an estimated $1.07K.
  • Gilead Sciences made up 0.02% of FinTrust Capital Advisors's portfolio in Q3 2024, its #399 holding.
  • FinTrust Capital Advisors first reported a position in Gilead Sciences in Q4 2018 and has held it in 24 quarters since.
  • FinTrust Capital Advisors's Gilead Sciences position peaked at $1.56M in Q2 2020.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.